Company news

Aclarion, Inc. news in 2023

Aclarion, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

November 26, 2023

Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption

November 7, 2023

Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD

November 5, 2023

Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver

October 24, 2023

Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting

October 23, 2023

Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan

October 22, 2023

Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report

August 24, 2023

Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI

June 13, 2023

Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting

June 7, 2023

Aclarion Announces New Engagement with The London Clinic and London Spine Clinic

May 29, 2023

Aclarion, Inc. Announces Delayed 10-Q Filing

May 22, 2023

Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts

May 18, 2023

Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial Evaluating Nociscan in the Diagnosis and Treatment of Chronic Low Back Pain

May 1, 2023

Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023

April 27, 2023

Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial

April 23, 2023

Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor

March 6, 2023

Gregory Basil MD to Join Aclarion as a Key Opinion Leader Surgeon Advisor

January 30, 2023

Aclarion Appoints George Frey MD as Seventh Key Opinion Leader Surgeon Advisor

January 16, 2023

Decks in 2023